标题
Galectin-3 in heart failure with preserved ejection fraction
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HEART FAILURE
Volume 15, Issue 10, Pages 1095-1101
出版商
Wiley
发表日期
2013-05-07
DOI
10.1093/eurjhf/hft077
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure
- (2013) A. Rogier van der Velde et al. Circulation-Heart Failure
- Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
- (2013) Inder S. Anand et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction
- (2013) Dirk J. van Veldhuisen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of Plasma Galectin‐3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
- (2013) Deepa M. Gopal et al. Journal of the American Heart Association
- Galectin‐3 in Heart Failure: More Answers or More Questions?
- (2013) Tariq Ahmad et al. Journal of the American Heart Association
- Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
- (2012) Laurent Calvier et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Renal Dysfunction in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction
- (2012) Finlay A. McAlister et al. Circulation-Heart Failure
- Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
- (2012) Lili Yu et al. Circulation-Heart Failure
- Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- (2012) L. Gullestad et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?
- (2012) Dirk J. van Veldhuisen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Aldosterone Inhibits Antifibrotic Factors in Mouse Hypertensive Heart
- (2012) Feriel Azibani et al. HYPERTENSION
- Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
- (2012) Jennifer E. Ho et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
- (2011) Akshay S. Desai et al. AMERICAN HEART JOURNAL
- Galectin-3 in Ambulatory Patients With Heart Failure
- (2011) G. Michael Felker et al. Circulation-Heart Failure
- Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
- (2011) Frank Edelmann et al. Clinical Research in Cardiology
- The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
- (2011) EUROPEAN HEART JOURNAL
- Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
- (2011) Patrick Collier et al. EUROPEAN JOURNAL OF HEART FAILURE
- The fibrosis marker galectin-3 and outcome in the general population
- (2011) R. A. de Boer et al. JOURNAL OF INTERNAL MEDICINE
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
- (2010) Rudolf A. de Boer et al. ANNALS OF MEDICINE
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
- (2010) Dirk J. A. Lok et al. Clinical Research in Cardiology
- Rationale and design of the ‘aldosterone receptor blockade in diastolic heart failure’ trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in pa
- (2010) Frank Edelmann et al. EUROPEAN JOURNAL OF HEART FAILURE
- Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
- (2010) Ravi V. Shah et al. EUROPEAN JOURNAL OF HEART FAILURE
- Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction
- (2010) Arantxa González et al. HYPERTENSION
- The Effect of Renin-Angiotensin System Inhibitors on Mortality and Heart Failure Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
- (2010) Ravi V. Shah et al. JOURNAL OF CARDIAC FAILURE
- Serum Galectin-3 Is Elevated in Obesity and Negatively Correlates with Glycosylated Hemoglobin in Type 2 Diabetes
- (2010) Johanna Weigert et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Epidemiology and risk profile of heart failure
- (2010) Anh L. Bui et al. Nature Reviews Cardiology
- Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure
- (2009) Wafae Iraqi et al. CIRCULATION
- Galectin-3: a novel mediator of heart failure development and progression
- (2009) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction
- (2009) Dirk J. van Veldhuisen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
- (2008) Yun-He Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Death in Heart Failure
- (2008) Danielle M. Henkel et al. Circulation-Heart Failure
- Galectin-3 in urine of cancer patients: stage and tissue specificity
- (2008) Kiruthika Balasubramanian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diastolic Stiffness of the Failing Diabetic Heart
- (2007) Loek van Heerebeek et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started